What is the appropriate treatment for comedones (blackheads) in the inframammary area?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Blackheads Under the Breast

Start with a topical retinoid as first-line therapy for comedonal acne in the inframammary area, ideally combined with benzoyl peroxide to enhance efficacy and prevent bacterial resistance. 1, 2

Primary Treatment Approach

For blackheads (open comedones) under the breast, topical retinoids are the cornerstone of therapy because they directly address the pathophysiology by:

  • Dissolving existing comedones (comedolytic action)
  • Preventing new microcomedone formation
  • Reducing inflammation

Specific Retinoid Options

Choose from these FDA-approved agents 1:

  • Adapalene 0.1% or 0.3% (cream or gel) - better tolerated than tretinoin, making it ideal for sensitive inframammary skin
  • Tretinoin 0.025-0.1% (cream, gel, or microsphere gel)
  • Tazarotene 0.05% or 0.1% (cream, gel, or foam) - most potent but may cause more irritation

Adapalene is the preferred choice for this location due to superior tolerability compared to older tretinoin formulations, which is particularly important in the warm, friction-prone inframammary area 1.

Combination Therapy (Recommended)

Add benzoyl peroxide 2.5-5% to the retinoid regimen 1, 2. This combination:

  • Enhances comedone clearance beyond retinoid monotherapy
  • Provides antibacterial coverage if any inflammatory component develops
  • Available as fixed-dose combinations (e.g., adapalene 0.1%-benzoyl peroxide 2.5% gel) which improve adherence 3

Alternative Combinations

If retinoids are not tolerated, consider 1:

  • Salicylic acid 0.5-2% (over-the-counter) - comedolytic but less effective than retinoids
  • Azelaic acid 20% - mildly comedolytic with additional benefit for post-inflammatory hyperpigmentation, particularly useful for darker skin types (Fitzpatrick IV-VI) common in inframammary hyperpigmentation 1

Application Strategy for Inframammary Area

Apply treatment to clean, completely dry skin:

  1. Wash area gently and pat completely dry (moisture increases irritation risk)
  2. Apply thin layer of retinoid at bedtime initially
  3. Start with every-other-night application for 2 weeks, then advance to nightly as tolerated
  4. Apply benzoyl peroxide in the morning if using separate products
  5. Use non-comedogenic moisturizer if dryness occurs

Important Caveats for This Location

The inframammary area presents unique challenges:

  • Higher risk of irritation due to occlusion from breast tissue and clothing
  • Increased moisture and friction
  • May require slower titration than facial application
  • Consider powder or gel formulations over creams to reduce occlusion

Avoid topical antibiotics as monotherapy - they should never be used alone due to resistance concerns 1, 2. If inflammatory lesions develop alongside comedones, combine antibiotics with retinoids and benzoyl peroxide.

When to Escalate

If comedones persist after 12 weeks of appropriate topical therapy 1:

  • Re-evaluate for macrocomedones (large, deep comedones) that may require physical extraction 4
  • Consider referral to dermatology for comedone extraction or cautery under local anesthesia
  • Rule out other conditions (hidradenitis suppurativa can present in inframammary area with comedone-like lesions) 5, 6

Maintenance

Continue topical retinoid indefinitely for maintenance even after clearance, as comedones will recur without ongoing therapy 1. This prevents microcomedone formation and maintains results.

References

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2016

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2024

Research

Hidradenitis suppurativa.

Lancet (London, England), 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.